DOI: 10.1017/ice.2026.10506 ISSN: 0899-823X
Assessing feasibility of real‑world respiratory virus syndromic surveillance in nursing homes using point‑of‑care molecular testing
Lisa F. Han, Ivis Perez, Kevin W. McConeghy, David H. Canaday, Elizabeth A. Sillman, Clare Nugent, Tiffany Wallace, Laurel Holland, Evan Dickerson, Olajide Olagunju, Debbie Keresztesy, Yasin Abul, Stefan Gravenstein, H. Edward DavidsonAbstract
Respiratory virus surveillance varies widely between nursing homes (NHs) and is shaped by differences in staffing capacity, provider training, diagnostic resources, and facility-level protocols. CLIA-waived, point-of-care molecular testing devices were implemented as routine respiratory virus surveillance in 23 Medicare-certified U.S. NHs to evaluate feasibility.